Cargando…

Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Schena, Francesco P, Tripepi, Giovanni, Rossini, Michele, Abbrescia, Daniela I, Manno, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050519/ https://www.ncbi.nlm.nih.gov/pubmed/35503549 http://dx.doi.org/10.1093/ckj/sfac063

Ejemplares similares

Randomized clinical study to evaluate the effect of personalized therapy on patients with immunoglobulin A nephropathy
por: Schena, Francesco P, et al.
Publicado: (2021)

The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy: Gene involvement in the mechanisms of inflammation and scarring in kidney biopsy of IgAN patients
por: Schena, Francesco Paolo, et al.
Publicado: (2021)

Understanding patient needs and predicting outcomes in IgA nephropathy using data analytics and artificial intelligence: a narrative review
por: Schena, Francesco Paolo, et al.
Publicado: (2023)

Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
por: Infante, Barbara, et al.
Publicado: (2020)

Correction to: Antiinflammatory constituents of Atractylodes chinensis rhizome improve glomerular lesions in immunoglobulin A nephropathy model mice
por: Ishii, Toshinari, et al.
Publicado: (2020)

Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers
por: Scarpati, Giuliana, et al.
Publicado: (2021)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Correction: Suramin: A Potential Therapy for Diabetic Nephropathy
Publicado: (2014)

Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation
por: Moroni, Gabriella, et al.
Publicado: (2019)

Correction: Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”. J. Clin. Med. 2019, 8, 1066
por: Russo, Domenico, et al.
Publicado: (2020)

Sucrose Nephropathy Following IV Immunoglobulin
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2010)

Chapter 10: Immunoglobulin A nephropathy
Publicado: (2012)

Significance of hyperuricemia in immunoglobulin A nephropathy
por: Nasri, Hamid, et al.
Publicado: (2013)

Clearance of BK Virus Nephropathy by Combination Antiviral Therapy With Intravenous Immunoglobulin
por: Kable, Kathy, et al.
Publicado: (2017)

A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2014)

Correction: Epidemiological and clinical aspects of immunoglobulin A vasculitis in childhood: a retrospective cohort study
por: Breda, Luciana, et al.
Publicado: (2022)

The complex of immunoglobulin A and uromodulin as a diagnostic marker for immunoglobulin A nephropathy
por: Obara, Takashi, et al.
Publicado: (2012)

Concurrent Drug-Induced Linear Immunoglobulin A Dermatosis and Immunoglobulin A Nephropathy
por: Kim, Ji Seok, et al.
Publicado: (2015)

Idiopathic immunoglobulin A nephropathy in children and adolescents
por: Hogg, Ronald J.
Publicado: (2009)

Kartagener syndrome complicated by immunoglobulin A nephropathy
por: Oka, Kentaro, et al.
Publicado: (2018)

Immunoglobulin A Nephropathy with Erythrocytosis: An Unusual Association
por: Navaradnam, Piratheepan, et al.
Publicado: (2021)

COVID-19 Vaccination in Immunoglobulin A Nephropathy
por: Lim, Cynthia Ciwei, et al.
Publicado: (2021)

Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
por: Chiricozzi, Andrea, et al.
Publicado: (2023)

Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathy
por: Westermann, Lukas, et al.
Publicado: (2023)

Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
por: Sausukpaiboon, Karnchanit, et al.
Publicado: (2022)

Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)

Correction to: In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: a population-based study
por: Ingrasciotta, Ylenia, et al.
Publicado: (2020)

A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease
por: Schena, Francesco Paolo, et al.
Publicado: (2020)

Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial
por: Wu, Jie, et al.
Publicado: (2016)

Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
por: Gharebaghi, Naser, et al.
Publicado: (2020)

Immunoglobulin Replacement Therapy in Secondary Hypogammaglobulinemia
por: Compagno, Nicolò, et al.
Publicado: (2014)

Correction: Towards the Personalized Treatment of Glioblastoma: Integrating Patient-Specific Clinical Data in a Continuous Mechanical Model
por: Colombo, Maria Cristina, et al.
Publicado: (2015)

Grave's disease associated with immunoglobulin A nephropathy: A rare association
por: Khan, I., et al.
Publicado: (2015)

Elevated serum immunoglobulin E level as a marker for progression of immunoglobulin A nephropathy
por: Lee, Ji-Hoon, et al.
Publicado: (2016)

Concurrent Linear Immunoglobulin A Dermatosis, Hashimoto Thyroiditis, and Immunoglobulin A Nephropathy in an Adult
por: Yang, Ji Young, et al.
Publicado: (2017)

Correction: Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real‑world study
por: Keith, Paul K., et al.
Publicado: (2023)

A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy
por: Dong, Ruijuan, et al.
Publicado: (2020)

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis
por: Lundberg, Sigrid, et al.
Publicado: (2017)

Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
por: Ballow, Mark, et al.
Publicado: (2018)

Color Doppler Ultrasound and Hemodynamics for Evaluating Graft Dysfunction in Recurrent Immunoglobulin A Nephropathy
por: Zhang, Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_apkjr0bbqgun0erb51gb8dts7n